Home / Health / Cutting-Edge Therapies Offer New Hope for Lowering Cholesterol

Cutting-Edge Therapies Offer New Hope for Lowering Cholesterol

Summary

  • 28 million U.S. adults have high cholesterol, often undiagnosed
  • New cholesterol-lowering injections and blood filtering procedures available
  • Genetic testing can identify unique cholesterol risks for personalized treatment
Cutting-Edge Therapies Offer New Hope for Lowering Cholesterol

According to the latest data from August 2025, a staggering 28 million adults in the United States have high cholesterol, putting them at increased risk of heart attacks and strokes. However, the true scope of the issue is even greater, as high cholesterol often presents no symptoms, leaving many unaware of their condition.

Fortunately, the medical community has made significant strides in developing new ways to lower cholesterol. In addition to the traditional approach of lifestyle changes and daily medications, patients now have access to cutting-edge treatments like cholesterol-lowering injections and a procedure called LDL apheresis that filters the blood to remove harmful lipids.

These advanced therapies are particularly beneficial for patients who have struggled to manage their cholesterol levels through other means. Genetic testing has also emerged as a valuable tool, allowing doctors to identify unique cholesterol risks and tailor treatment plans accordingly. With these innovative approaches, healthcare providers can now offer more comprehensive and effective solutions to combat the high cholesterol epidemic.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

Patients can now access cholesterol-lowering injections like PCSK9 inhibitors and Inclisiran, as well as a blood filtering procedure called LDL apheresis to remove harmful lipids.
Genetic testing can identify unique cholesterol risks for individual patients, allowing healthcare providers to develop personalized treatment plans to better manage their condition.
As of August 2025, a staggering 28 million adults in the U.S. have been diagnosed with high cholesterol, a leading cause of heart attacks and strokes.

Read more news on